Author： Cohen A.
Publisher： Adis International
ISSN： 1173-8804
Source： BioDrugs, Vol.11, Iss.2, 1999-02, pp. : 115-123
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
What is the Practical Significance of Antibodies to Interferons?
By Dianzani F.
BioDrugs, Vol. 9, Iss. 3, 1998-03 ,pp. :
Clinical Significance of Epithelial Peptide Antibiotics
BioDrugs, Vol. 11, Iss. 5, 1999-05 ,pp. :
Recombinant Clotting Factors: A Review of Current Clinical Status
By Lusher J.M.
BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. :
Recombinant Hirudin: Clinical Pharmacology and Potential Applications in Nephrology
BioDrugs, Vol. 11, Iss. 6, 1999-06 ,pp. :